Research programme: VEGF gene therapy - Trizell
Alternative Names: Ad VEGF-D variants; EG013Latest Information Update: 23 Nov 2012
At a glance
- Originator Ark Therapeutics
- Class Gene therapies
- Mechanism of Action Gene transference; Vascular endothelial growth factor A expression stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Discontinued Fetal growth retardation